Evidence map›Paper›PMID 41084902›Full record

ArticleFuture microbiology2025

Chlorpromazine, impregnated in foley catheter fragments, as an antibiofilm agent to control urinary tract infections.

Bruno Rocha Amando, José Júlio Costa Sidrim, Francisco Ivanilsom Firmiano Gomes, Carliane Melo Melgarejo, Paulo Roberto Honório de Souza, Rodrigo Fonseca de Medeiros Guedes, Vicente Maciel Dantas Júnior, Fernando Victor Monteiro Portela, Glaucia Morgana de Melo Guedes, Rossana de Aguiar Cordeiro and 4 more

Abstract read
In one paragraph

Article in Future microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bruno Rocha AmandoDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
José Júlio Costa SidrimDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Francisco Ivanilsom Firmiano GomesDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Carliane Melo MelgarejoDepartment of Physiology and Pharmacology. Postgraduate Program in Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Paulo Roberto Honório de SouzaDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Rodrigo Fonseca de Medeiros GuedesDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Vicente Maciel Dantas JúniorDepartment of Physiology and Pharmacology. Postgraduate Program in Pharmacology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Fernando Victor Monteiro PortelaDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Glaucia Morgana de Melo GuedesDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Rossana de Aguiar CordeiroDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, Federal University of Ceará, Fortaleza, Ceará, Brazil.ORCID 0000-0001-8386-2180
Marcos Fábio Gadelha RochaDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Center, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Débora de Souza Collares Maia Castelo-BrancoDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Paulo César Pereira de SousaWalter Cantídio University Hospital, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Giovanna Barbosa RielloDepartment of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study proposes to evaluate the impregnation of Foley catheters, in different concentrations of CPZ, to control the formation of biofilms in vitro by the uropathogens most commonly associated with indwelling catheters. MATERIALS &

methodsMinimum inhibitory concentrations (MICs) for CPZ and the effect of CPZ (at different concentrations) on biofilm formation were evaluated. Biofilm formation and the effect of CIP and MER on mature biofilms in CPZ-impregnated catheters were evaluated.

resultsThe CPZ MIC was 312.5-625 µg/ml. CPZ significantly (p < 0.05) disrupted biofilm formation at all tested concentrations. In addition, the tested CPZ potentiated the action of CIP.

conclusionsOur results suggest the use of CPZ by impregnation of catheters can prevent the formation of bacterial biofilms, preventing urinary infections through this route.

Indexed as

Anti-Bacterial AgentsBiofilmsChlorpromazineUrinary CathetersUrinary Tract InfectionsCatheter-Related InfectionsCatheters, IndwellingHumansMicrobial Sensitivity TestsUrinary CatheterizationAnti-Bacterial AgentsChlorpromazinebiofilmsChlorpromazineenterobacteriaceaepseudomonas aeruginosaurinary tract infections

Identifiers

PMID41084902
PMCPMC12667643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.